Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Costs of breast cancer care by stage and HER-2 Status: a population-based study.

Frontiers in health services·2026
Same author

Atrophic gastritis of distinct etiologies: malignant potential in <i>Helicobacter pylori</i>-associated and autoimmune forms.

Annals of gastroenterology·2026
Same author

Autoimmune Gastritis Diagnosis: Encompassing Pessimism, Realism, and Wish for the Future. Comment on Vienneau et al. Autoimmune Metaplastic Atrophic Gastritis Reporting: Are Pathologists and Endoscopists on the Same Page? <i>Diagnostics</i> 2025, <i>15</i>, 2906.

Diagnostics (Basel, Switzerland)·2026
Same author

Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis.

Cancers·2026
Same author

Gastric cancer in autoimmune gastritis: ranking the risk.

Journal of gastroenterology·2026
Same author

Gastric cancer secondary prevention in dyspeptic patients.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026

Related Experiment Video

Updated: Jul 19, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Assessing risks for gastric cancer: new tools for pathologists.

Robert M Genta1, Massimo Rugge

  • 1Pathology and Laboratory Service-113, VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216, USA. robert.genta@utsouthwestern.edu

World Journal of Gastroenterology
|September 29, 2006
PubMed
Summary

The Sydney Systems for gastritis classification need improvement for immediate gastric cancer risk assessment. Integrating histopathology with lab data offers a better approach for patient management.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Related Experiment Videos

Last Updated: Jul 19, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Area of Science:

  • Gastroenterology
  • Pathology
  • Oncology

Background:

  • The Sydney Systems (original and updated) standardize gastritis reporting.
  • Current systems lack immediate gastric cancer risk information.
  • Gastritis is a precursor to gastric cancer.

Purpose of the Study:

  • To review gastric lesions associated with increased cancer risk.
  • To propose enhanced gastritis reporting methods.
  • To improve clinical management of gastric conditions.

Main Methods:

  • Review of current understanding of gastritis and cancer risk.
  • Proposal for integrating histopathological grading/staging with lab data (pepsinogens, gastrin).
  • Evaluation of the Sydney System's limitations.

Main Results:

  • Identified key gastric lesions linked to elevated cancer risk.
  • Proposed a new reporting framework for gastritis.
  • Highlighted the value of integrating diverse diagnostic data.

Conclusions:

  • Enhanced gastritis reporting can improve cancer risk communication.
  • Integrating histopathology with serological markers (pepsinogens, gastrin) aids clinical decisions.
  • A revised reporting system facilitates timely patient management for gastric conditions.